| Literature DB >> 35720345 |
Minh H Tran1,2,3, Clara T Schoeder2,4,5, Kevin L Schey3, Jens Meiler2,4,5.
Abstract
Although computational structure prediction has had great successes in recent years, it regularly fails to predict the interactions of large protein complexes with residue-level accuracy, or even the correct orientation of the protein partners. The performance of computational docking can be notably enhanced by incorporating experimental data from structural biology techniques. A rapid method to probe protein-protein interactions is hydrogen-deuterium exchange mass spectrometry (HDX-MS). HDX-MS has been increasingly used for epitope-mapping of antibodies (Abs) to their respective antigens (Ags) in the past few years. In this paper, we review the current state of HDX-MS in studying protein interactions, specifically Ab-Ag interactions, and how it has been used to inform computational structure prediction calculations. Particularly, we address the limitations of HDX-MS in epitope mapping and techniques and protocols applied to overcome these barriers. Furthermore, we explore computational methods that leverage HDX-MS to aid structure prediction, including the computational simulation of HDX-MS data and the combination of HDX-MS and protein docking. We point out challenges in interpreting and incorporating HDX-MS data into Ab-Ag complex docking and highlight the opportunities they provide to build towards a more optimized hybrid method, allowing for more reliable, high throughput epitope identification.Entities:
Keywords: antibody-antigen interaction; epitope-paratope identification; hydrogen-deuterium exchange mass spectrometry (HDX-MS); integrative structural biology; protein-protein docking; structure modeling
Mesh:
Substances:
Year: 2022 PMID: 35720345 PMCID: PMC9204306 DOI: 10.3389/fimmu.2022.859964
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 8.786
Figure 1Overview of a typical workflow for an epitope/paratope mapping HDX-MS experiment. Separately, the Ag, Ab-Ag complex, and Ab are labeled in D2O and incubated for varying lengths of time. The reactions are then quenched at low pH and low temperature. The protein samples are digested (typically with pepsin) to generate peptide fragments. Peptide fragments from each sample are analyzed using LC-MS to identify mass differences at various time points. The D uptake altered by binding enables identification of putative paratope and epitope peptides. Figure is adapted from (20).
Figure 2Experimental limitations when using HDX-MS for epitope mapping.
Current alternative or complementary experimental approaches and their pros and cons regarding each HDX-MS experimental limitation.
| HDX-MS limitations | Alternative/complementary approaches | Short description | Advantages | Disadvantages |
|---|---|---|---|---|
| Peptide-level resolution | Gas-phase fragmentation: electron transfer dissociation (ETD) or electron capture dissociation (ECD) ( | -Peptide ions are fragmented by ETD/ECD instead of CID. The ck and zk fragment ions report the nascent D content of the associated fraction of the parent peptide ion | -With gentle ESI conditions, fragments from ETD/ECD are accompanied by little to no H/D scrambling and can be solved to determine the D occupancy with resolution approaching residue level |
-H/D scrambling can still occur without the optimized ion optics and gentle ESI conditions -Lack of easy-to-use and reliable software for ETD/ECD data processing -Impractical for routine implementation |
| Insufficient peptide coverage (specifically with large complexes, highly glycosylated Ag, and disulfide-bonded Ab) | Ion mobility spectrometry (IMS) ( | -Incorporation of IMS after the chromatography step deconvolutes unresolved overlapping peptides in chromatographic separation | -Increases the resolving power for overlapping mass-spectra and allows for identification of more peptides | -Challenge in routinely incorporating IMS in HDX-MS experiment (complicated experimental setup) |
| Enzymatic deglycosylation of the glycoprotein ( | -PNGase F prior to HDX-MS labeling |
-Easy to implement -Reduces complexity of resulting peptides -Enhances detectability of glycosylated regions of the protein |
-Risk destabilizing native structure of the Ag and can lead to aggregation -May misinterpret Ab-Ag interacting site | |
| -PNGase A or PNGase H+ after HDX-MS labeling | -Allows characterization of the native conformational dynamics and interaction at the glycosylation sites | -Requires offline pepsin digestion and manual sample injection into the LC-MS system | ||
| Disulfide bond reduction for Ab ( | -The chemical reductant TCEP is commonly added to the quench buffer at high concentration | -Protein becomes more protease susceptible and increases sequence coverage | -Can deteriorate both LC and MS performance | |
| Improve digestion efficiency ( |
-Multiple replicate pepsin digestions -Alter digestion conditions (e.g., off-line digestion, denaturants, etc) -Change to or supplement with another protease |
-Produces more reproducible peptides -Generates many new short and overlapping peptide fragments due to different cleavage specificities of different digestive enzymes | -Material and time cost of experiment increases | |
| Discern the difference between direct binding interface and allosteric conformational change | Complementary experiments and assays ( |
-Site-directed mutagenesis followed by functional assays -Disulfide trapping in cells -Chemical crosslinking with MS -Kinetic millisecond HDX-MS (TRESI-HDX) | -Provides additional information to increase the certainty and better define the directly contacting regions | -Might need to try multiple approaches to reach a conclusion |
Figure 3Schematic of base catalysis HDX of amide backbone protons in solution. Figure is reproduced from (57).
Figure 4Flowchart of HDX-MS data simulation to validate plausible protein models. For each protein model, PF at each amide position is predicted. From PF and the intrinsic exchange rate k ch, the D value of each residue is calculated. HDX-MS data for each peptide (from the experimental peptide list) is generated by summing D uptake of the member residues. The simulated HDX-MS profiles of protein models are compared with the experimental data normalized for back exchange. Matching D profiles of multiple peptides validates the protein model, facilitating differentiation between native and non-native models.
Figure 5The protein-protein docking procedure from RosettaDock – a multiscale Monte-Carlo based algorithm with different stages for HDX-MS data to be incorporated. HDX-MS data can be applied to the sampling stage (including the arrangement of the starting pose, low-resolution docking, and high-resolution docking) as well as the scoring stage. Figure is adapted from (102).
A summary of studies integrating HDX-MS and docking to predict Ab-Ag native poses and their performance.
| Studies | Docking algorithms | Docked Ag | Docked Ab | Sampling and applying HDX restraints | Model selection | Evaluation |
|---|---|---|---|---|---|---|
| ( | ZDOCK (in combination with ZRANK and RDOCK) | crystal structure | crystal structure (Fab) or homology modeled antibody (Fv) using RosettaAntibody protocol | -54000 poses were sampled in ZDOCK | -The top 10 poses from RDOCK refinement process were selected for evaluation | -Compared to stand-alone docking, the HDX-MS-derived restraints significantly improved the docking results for one of the three testing Ab-Ag complexes: the number of “hit” poses among top 10 poses generated increased from four to seven, with the iRMSD of the highest-ranking pose being 1.4 Å to the complex crystal structure |
| ( | MOE | crystal structure | models of HDX-predicted antibody peptides were generated with MOE | -HDX-predicted epitope peptides were set as the docking sites | -Five (MOE) to ten (PatchDock and ZDOCK) molecular dynamics-minimized docking poses were selected for evaluation | -For all three software packages, computational docking with HDX-MS data produced more “hit” residues than docking without HDX-MS data. In other words, more ‘hit’ residues were detected for docking at the HDX-specified site compared to randomly selected sites |
| PatchDock | -HDX-predicted epitope peptides were set either as the docking sites or as volume-constraint pharmacophores | |||||
| ZDOCK | -HDX non-epitope residues of the antigen were blocked as a scoring penalty | |||||
| ( | MOE | crystal structure | Homology modeled antibody (Fab) using Bioluminate protocol v1.9 and MAESTRO v10.2 | -100,000 starting poses were sampled using MOE | -The top 200 poses were evaluated for surface complementarity based upon AMBER complementarity score (24) and visual inspection of surfaces as implemented in the protein_contact_surfaces script implemented in MOE | -The best docking poses were proposed to be the Ab-Ag interaction model. The HDX-predicted peptides in this model were at the interface and were corroborated by the SASA analysis |
| ( | Rosetta | crystal structure | crystal structure (Fab) | -Restrict docking in Rosetta to HDX-predicted epitope of the antigen and the CDRs region of antibody | -An ensemble of 25 best-scoring models (by binding energy) that fulfilled HDX constraints were selected | -The best docking poses were proposed to be the Ab-Ag interaction model. Functional assays were performed, and the results endorsed the binding modes of the docked complexes |
| ( | PatchDock | crystal structure | Homology modeled Ab (Fv) using ABodyBuilder Fv prediction | -HDX-predicted epitopes were set as docking sites by adding a scoring parameter to PatchDock | -The top 100 poses were evaluated for CDR inclusion at the interface and agreement to the alanine scan data. Among these, the top two poses were selected | - HDX profile simulation was performed using the ‘calc-HDX’ function of the HDXer tool for the top two docked structures |
Figure 6Different practices have been used to incorporate HDX-MS data into Ab-Ag docking. HDX-MS data are provided in form of identified epitope peptides (e.g., peptide 219-230 with a decrease in deuterium level of at least 4Da across 4 timepoints). Docking components: Ag crystal structure (blue; HDX-identified peptide: red) and Ab (Fab or Fv) crystal structure or homology model - (yellow; CDRs: pink). Sampling stage: (A) Restrain the docking sites. Favorable potential (red sphere) - spheres surrounding the backbone N atoms in the epitope are filled with favorable values. Each atom of the Ab lying within this sphere would contribute a favorable potential to the energy function. Distance restraint (left right arrows) - a minimum number of residues from each epitope peptide must be within a specified threshold distance to the Ab. Lenient approach: one residue from the epitope peptide to be at the interface. Stringent approach: the minimum number of contact residues correlates with the decrease in deuterium level (i.e., 4 residues in this case). (B) Restrain the non-docking sites: non-epitope peptides and non-CDR regions (grey) are blocked from docking using distance restraint. Scoring stage: HDX-MS data is applied as filters in form of: the number of satisfied distance restraints is - the higher the count (favorable contact) is, the more optimal a docked pose is considered to be; visual analysis - manually inspection of the docked poses on whether the epitope is at the interface; SASA evaluation - SASA calculation of the epitope peptide in the unbound form must be larger than the bound form.
Figure 7Challenges of HDX-MS data incorporation into docking. 1) Quantitative HDX-MS restraint: HDX-MS data is incapable of providing quantitative geometric distances between atoms, thus, hindering its application to the sampling process. 2) Potential misinterpretation of HDX-MS data. True positive signals can be undetected due to insufficient coverage and inherent blind spots or overlooked. False positive signals are very probable due to manual data interpretation, noise, and allosteric effects. 3) HDX-MS weighted scoring function. The evaluation of docking poses based on HDX-MS data is still largely qualitative. 4) High-quality dataset for benchmarking. HDX-MS data and crystal structure of an Ab-Ag complex in most cases are exclusively available. There is a need for establishing a database for HDX-MS epitope mapping data.